Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Startups channel feed
Lilly-partnered Fauna Bio plans $40M Series A to get into heart failure
2 months ago
Financing
Montara Therapeutics adds $20M to seed fundraise for neurology pipeline
2 months ago
Financing
Insilico nabs $110M Series E for AI drug discovery after stalling Hong Kong IPO plans
2 months ago
Financing
AI
New Flagship startup aims to trailblaze ‘AI science factories’
2 months ago
AI
At $300M Kardigan startup, former MyoKardia team unveils its first drug, and it comes from Ionis
2 months ago
Deals
Pharma
Longtime biotech investor Frazier Life Sciences is raising its latest venture fund
2 months ago
Financing
Lilly, Pfizer invest in UK startup's seed round for neurodegeneration protein degraders
2 months ago
Financing
Swiss biotech ends Phase 2 study in Alzheimer's shortly after Lilly and Biogen did the same
2 months ago
R&D
Sofinnova Partners raises €1.2B to back another 50 to 60 life sciences startups
2 months ago
Financing
ADCs from a decade-old Singapore biotech find new life with $187M
2 months ago
Financing
Deals
BridgeBio oncology spinout to go public via combination with SPAC from Cormorant and Bihua Chen
2 months ago
Deals
Pharma-backed Mission Therapeutics stops preclinical operations, focuses on two clinical assets
2 months ago
People
Kallyope quietly reports Phase 2 obesity data, begins mid-stage migraine trial
2 months ago
R&D
Eikon Therapeutics raises $351M Series D as lead drug starts Phase 3
2 months ago
Financing
Chicago biotech Emalex says it cleared a Phase 3 for Tourette syndrome, will seek FDA approval
2 months ago
R&D
En vogue Chinese ADC biotech lets Hong Kong IPO filing lapse
2 months ago
Financing
China
BridGene nets another Takeda deal amid plans to raise more funding and go public
2 months ago
Deals
Pharma
How Keymed steered the China-to-US NewCo model in biotech
3 months ago
Deals
China
Paris startup collects €27M in Series B to advance overactive bladder treatment
3 months ago
Financing
Startup that mines ‘junk DNA’ secures R&D deal with Merck
3 months ago
Deals
Exclusive: CRISPR delivery startup, based on UC Berkeley and UCSF science, shuts down
3 months ago
R&D
Exclusive: Lux leads $25M Series A in a Lithuanian startup plotting US expansion
3 months ago
Financing
Pain biotech Latigo eyes up to $150M raise following Vertex's landmark FDA nod
3 months ago
Financing
Kojin Therapeutics shuts down, citing lack of investor interest and complex science
3 months ago
People
First page
Previous page
1
2
3
4
5
6
7
Next page
Last page